REVELATION BIOSCIENCES, INC.
REVBNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for REVB. That does not mean none is planned.
Get an email about REVB's next catalysts
Track REVELATION BIOSCIENCES (REVB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
REVB Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-6.16 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Intravenous Gemini | Phase 2 | Renal Insufficiency, Chronic | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in REVELATION BIOSCIENCES, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in REVELATION BIOSCIENCES, INC.'s (REVB) pipeline across Phase 2. Its lead program is Intravenous Gemini (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is REVELATION BIOSCIENCES, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for REVELATION BIOSCIENCES, INC. (REVB) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track REVB biotech catalysts?→
Add REVB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow REVELATION BIOSCIENCES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.